Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia-Reference-Cited by-同舟云学术

Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia

Published:2024-06-24 Issue:1 Volume:14 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Salustiano-Bandeira Maria L.,Moreira-Aguiar Amanda,Pereira-Martins Diego A.^ORCID,Coelho-Silva Juan L.^ORCID,Weinhäuser Isabel^ORCID,França-Neto Pedro L.,Lima Aleide S.,Lima Ana S.,Baccarin Anemari R.,Silva Fernanda B.,de Melo Manuela A.^ORCID,Niemann Fernanda S.,Nardinelli Luciana,Ortiz Rojas César A.,Duarte Bruno K.^ORCID,Araujo Aderson S.,Azevedo Elisa A.,Morais Clarice N.,Figueiredo-Pontes Lorena L.,Schuringa Jan J.,Huls Gerwin,Bendit Israel^ORCID,Rego Eduardo M.,Olalla Saad Sara T.,Traina Fabiola^ORCID,Bezerra Marcos A.,Lucena-Araujo Antonio R.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41408-024-01086-8.pdf

Reference14 articles.

1. Jost CA, Marin MC, Kaelin WG Jr. p73 is a human p53-related protein that can induce apoptosis. Nature. 1997;389:191–4. http://www.nature.com/articles/38298.

2. Ishimoto O, Kawahara C, Enjo K, Obinata M, Nukiwa T, Ikawa S. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Cancer Res. 2002;62:636–41. http://www.ncbi.nlm.nih.gov/pubmed/11830511.

3. Lucena-Araujo AR, Kim HT, Thomé C, Jacomo RH, Melo RA, Bittencourt R, et al. High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia. Blood. 2015;126:2302–6. http://www.ncbi.nlm.nih.gov/pubmed/26429976.

4. Pereira-Martins D, Ortiz Rojas CA, Weinhaeuser I, Wierenga BJ, Van Den Boom V, Mojallali F, et al. CEBPA-driven expression of the transcriptionally inactive deltaTP73 isoform phenocopies TP53 mutated poor risk and drug-resistant acute myeloid leukemia. Blood. 2023;142:839–839.

5. Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77.